Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
The Canadian biotechnology market had total revenue of $2,863.2 million in 2010, representing a compound annual rate of change (CARC) of -11% between 2006 and 2010.
Medical/Healthcare sales proved the most lucrative for the Canadian biotechnology market in 2010, with total revenues of $1,960.2 million, equivalent to 68.5% of the market's overall value.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 28.5% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $10,043 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Canada

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Canada

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Canada biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Canada economy

Key Questions Answered

What was the size of the Canada biotechnology market by value in 2010?

What will be the size of the Canada biotechnology market in 2015?

What factors are affecting the strength of competition in the Canada biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Canada's biotechnology market?

EXECUTIVE SUMMARY
MARKET OVERVIEW
- Market definition
- Research highlights
- Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
FIVE FORCES ANALYSIS
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
LEADING COMPANIES
- Amgen
- Baxter International Inc
- Covance Inc.
- MDS Financial Group Limited
MARKET FORECASTS
- Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
- Methodology
- Industry associations
- Related Datamonitor research
- Disclaimer
ABOUT DATAMONITOR
- Premium Reports
- Summary Reports
- Datamonitor consulting
LIST OF TABLES
- Table 1: Canada biotechnology market value: $ million, 2006-10
- Table 2: Canada biotechnology market segmentation I:% share, by value, 2010
- Table 3: Canada biotechnology market segmentation II: % share, by value, 2010
- Table 4: Amgen: key facts
- Table 5: Amgen: key financials ($)
- Table 6: Amgen: key financial ratios
- Table 7: Baxter International Inc: key facts
- Table 8: Baxter International Inc: key financials ($)
- Table 9: Baxter International Inc: key financial ratios
- Table 10: Covance Inc.: key facts
- Table 11: Covance Inc.: key financials ($)
- Table 12: Covance Inc.: key financial ratios
- Table 13: MDS Financial Group Limited: key facts
- Table 14: MDS Financial Group Limited: key financials ($)
- Table 15: MDS Financial Group Limited: key financial ratios
- Table 16: Canada biotechnology market value forecast: $ million, 2010-15
- Table 17: Canada size of population (million), 2006-10
- Table 18: Canada gdp (constant 2000 prices, $ billion), 2006-10
- Table 19: Canada gdp (current prices, $ billion), 2006-10
- Table 20: Canada inflation, 2006-10
- Table 21: Canada consumer price index (absolute), 2006-10
- Table 22: Canada exchange rate, 2006-10
LIST OF FIGURES
- Figure 1: Canada biotechnology market value: $ million, 2006-10
- Figure 2: Canada biotechnology market segmentation I:% share, by value, 2010
- Figure 3: Canada biotechnology market segmentation II: % share, by value, 2010
- Figure 4: Forces driving competition in the biotechnology market in Canada, 2010
- Figure 5: Drivers of buyer power in the biotechnology market in Canada, 2010
- Figure 6: Drivers of supplier power in the biotechnology market in Canada, 2010
- Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2010
- Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2010
- Figure 9: Drivers of degree of rivalry in the biotechnology market in Canada, 2010
- Figure 10: Amgen: revenues & profitability
- Figure 11: Amgen: assets & liabilities
- Figure 12: Baxter International Inc: revenues & profitability
- Figure 13: Baxter International Inc: assets & liabilities
- Figure 14: Covance Inc.: revenues & profitability
- Figure 15: Covance Inc.: assets & liabilities
- Figure 16: MDS Financial Group Limited: revenues & profitability
- Figure 17: MDS Financial Group Limited: assets & liabilities
- Figure 18: Canada biotechnology market value forecast: $ million, 2010-15

Pharmaceutical Market Research

Biotechnology in Canada